alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 14**  **- 2409** 

IN RE: DAVID A. STEBBINS , Petitioner.

On Petition for Writ of Mandamus. ( 1:14

- cv - 00961

- CMH

- TCB ; 1:14

- cv - 01267

- CMH

- TCB )

Submitted : April 23, 2015 Decided: April 27, 2015

Before SHEDD, DUNCAN, and THACKER , Circuit Judges.

Petition denied by un published per curiam opinion
.
David A. Stebbins, Petitioner Pro Se
. Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: David A. Stebbins, who has two civil actions pending in the district court, p etitions for a writ of mandamus alleging the district court has unduly delayed acting on a summary judgment motion pending in one of the actions, and that it has delayed ruling on a motion for joinder of parties pending in the other civil action. He seeks an order from this court directing the district court to act. Our review of the district court’s dockets reveals that the district court granted the summary judgment motion and denied St ebbins’ motion for joinder
. Accordingly, although we grant leave to proceed in forma pauperis, we deny the mandamus petition as moot. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

PETITION DENIED
[Federal Register Volume 87, Number 3 (Wednesday, January 5, 2022)]
[Notices]
[Page 425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28557]



[[Page 425]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-61-2021]


Foreign-Trade Zone (FTZ) 261--Alexandria, Louisiana, 
Authorization of Production Activity, Avant Organics LLC (Specialty 
Chemicals), Alexandria, Louisiana

    On September 1, 2021, Avant Organics LLC submitted a notification 
of proposed production activity to the FTZ Board for its facility 
within FTZ 261, in Alexandria, Louisiana.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 50324, September 8, 2021). On 
December 30, 2021, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: December 30, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021-28557 Filed 1-4-22; 8:45 am]
BILLING CODE 3510-DS-P
| Exhibit 32.1                 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO                              SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
      In connection with the Quarterly Report of Palomar Medical Technologies, Inc. (the “Company”) onForm 10-Q for the period ended June 30, 2009 as filed with the Securities and Exchange Commission (the“Report”), I, Joseph P. Caruso, and I, Paul S. Weiner certify, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to our knowledge:     (1)    
      The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities      Exchange Act of 1934; and
     (2)    
       The information contained in the Report fairly presents, in all material respects, the financial      condition and results of operations of the Company.

              A signed original of this written statement required by Section 906 has been provided to theCompany and will be retained by the Company and furnished to the Securities and Exchange Commission orits Staff upon request.Dated: August 5, 2009      By:   /s/ Joseph P. Caruso         Joseph P. Caruso President and Chief Executive Officer    Dated: August 5, 2009      By:   /s/ Paul S. Weiner         Paul S. Weiner Chief Financial Officer    |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Exhibit 32.2

ZORAN CORPORATION  CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Zoran Corporation (the "Company") on Form 10-K for the period ended December 31, 2003, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"), I, Karl Schneider, Senior Vice President, Finance and Chief Financial Officer of the Company, hereby certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

A
signed original of this written statement required by Section 906 has been provided to Zoran Corporation and will be retained by Zoran Corporation and furnished to the
Securities and Exchange Commission or its staff upon request.

|Dated: March 15, 2004 | /s/KARL SCHNEIDERKarl Schneider
Senior Vice President, Finance and
Chief Financial Officer
|--------------------- | ------------------------------------------------------------------------------------------

---

QuickLinks
August 8, 2016

Mr. James Quilty

CEO

Sofia Information Technology Consulting, Inc.

120 E. Logarto Circle

Suite D-114

Tampa, FL 33612

Re: FAA–2016–4019

Dear Mr. Quilty:

This letter is to provide notification that we have reviewed your petition for exemption, and 

have determined that we will continue to process your petition. 

As referenced in the June 22, 2016, letter posted to your docket at www.regulations.gov, we 

are reviewing pending Section 333 petitions to determine if the recently-issued regulation, 

Operation and Certification of Small Unmanned Aircraft Systems, Title 14, Code of Federal 

Regulations, Part 107 (www.faa.gov/uas) will satisfy your request. We have determined that 

your request requires further regulatory relief (Tier 3), and we will continue working on your 

petition for exemption. 

We have found that your petition, if granted, would set a precedent. Therefore, we will 

publish a summary of your petition in the Federal Register for public comments, if we have 

not done so already.

We will advise you of the agency’s final decision on your petition as soon as possible. If you 

have any questions regarding your petition, please contact me at 333exemptions@faa.gov. 

Sincerely,

/s/

Brenda Robeson

Program Analyst
EXHIBIT 32.1

STATEMENT OF CHIEF EXECUTIVE OFFICER
OF PREMIERE GLOBAL SERVICES, INC.
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
§ 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Premiere Global Services, Inc. (the Company) on Form 10-Q for the quarter ended March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Boland T. Jones, Chief Executive Officer of the Company, certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                               
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|
| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|             |                               
|------------ | ------------------------------
|May 10, 2010 | /s/ Boland T. Jones           
|             |                               
|             | Boland T. Jones               
|             | Chief Executive Officer       
|             | Premiere Global Services, Inc.

---
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFROMATION EXTRACTED FROM THE
ANNUAL REPORT ON FORM 10-KSB FOR THE YEAR ENDED JUNE 30, 1997 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                             233
<INT-BEARING-DEPOSITS>                             575
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      9,850
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                         52,530
<ALLOWANCE>                                        226
<TOTAL-ASSETS>                                  64,875
<DEPOSITS>                                      44,754
<SHORT-TERM>                                     1,750
<LIABILITIES-OTHER>                                724
<LONG-TERM>                                      6,902
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             7
<OTHER-SE>                                      10,668
<TOTAL-LIABILITIES-AND-EQUITY>                  64,875
<INTEREST-LOAN>                                  4,128
<INTEREST-INVEST>                                  862
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                 4,990
<INTEREST-DEPOSIT>                               2,216
<INTEREST-EXPENSE>                               2,553
<INTEREST-INCOME-NET>                            2,437
<LOAN-LOSSES>                                       40
<SECURITIES-GAINS>                                 388
<EXPENSE-OTHER>                                  1,712
<INCOME-PRETAX>                                    915
<INCOME-PRE-EXTRAORDINARY>                         565
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       565
<EPS-PRIMARY>                                      .91
<EPS-DILUTED>                                      .91
<YIELD-ACTUAL>                                    3.97
<LOANS-NON>                                          0
<LOANS-PAST>                                       229
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   209
<CHARGE-OFFS>                                       33
<RECOVERIES>                                        10
<ALLOWANCE-CLOSE>                                  226
<ALLOWANCE-DOMESTIC>                               226
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                             11
        

</TABLE>
II 

Calendar No. 629 

111TH CONGRESS 

2D SESSION H. R. 4543 

IN THE SENATE OF THE UNITED STATES 

APRIL 27, 2010 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

SEPTEMBER 29, 2010 

Reported by Mr. LIEBERMAN, without amendment 

AN ACT 

To designate the facility of the United States Postal Service 

located at 4285 Payne Avenue in San Jose, California, 

as the ‘‘Anthony J. Cortese Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ANTHONY J. CORTESE POST OFFICE BUILDING. 

4 (a) DESIGNATION.—The facility of the United States 

5 Postal Service located at 4285 Payne Avenue in San Jose, 

6 California, shall be known and designated as the ‘‘Anthony 

7 J. Cortese Post Office Building’’. 

mstockstill on DSKH9S0YB1PROD with BILLS

2 

•HR 4543 RS

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘Anthony J. Cortese 

5 Post Office Building’’. 

mstockstill on DSKH9S0YB1PROD with BILLS

mstockstill on DSKH9S0YB1PROD with BILLS

Calendar No. 629 

111TH CONGRESS 

2D SESSION H. R. 4543 

AN ACT 

To designate the facility of the United States PostPost Office Building’’. Jose, California, as the ‘‘Anthony J. Cortese al Service located at 4285 Payne Avenue in San 

SEPTEMBER 29, 2010 

Reported without amendment 

mstockstill on DSKH9S0YB1PROD with BILLS
#### John Eichman, Receiver of the North Schuylkill Mutual Fire Insurance Company *v.*John Hersker, Appellant.

Argued Feb. 21, 1895.

Appeal, No. 302, Jan. T., 1895, by defendant, from judgment of C. P. Schuylkill Co., May. T., 1886, No. 13, on verdict for plaintiff.

Before Gkeen, Williams, McCollum, Dean and Fell, JJ.

Affirmed.

*415Assumpsit to recover assessment on policy No. 525. Before Pershing, P. J.

See next preceding case.

October 7, 1895:

Opinion by

Mr. Justice Dean,

This case is in no essential particular different from No. 801, January term, 1895, in which opinion is filed herewith; therefore the same decree, “ Judgment affirmed, and appeal dismissed at costs of appellant,” is herewith entered.
#### Mary M. Shepard et al. *v.*Montgomery National Bank et al., Appellants.

*Wills*— Issue *devisavit vel non*— Standing *of creditors of heirs to contest will.*

The creditor of an heir has no standing to contest a will by which the heir is excluded from participating in his ancestor’s estate. Shepard’s Estate, next preceding case.

Argued Feb. 4, 1895.

Appeal, No. 444, Jan. T., 1894, by defendants, from judgment of C. P. Montgomery Co., on verdict for plaintiffs.

Before Sterrett, C. J., Green, Williams, Mitchell and Dean, JJ.

Affirmed.

Issue devisavit vel non. Before Weand, J.

At the trial defendants claimed that the will was forged.

The facts appear in the opinion of the Supreme Court in this case and in the next preceding one.

Verdict and judgment for plaintiffs. Defendants appealed.

*Errors assigned*were various instructions immaterial to this report.

*Louis M. Childs*and *Charles*Eunsielcer, *Montgomery Evans*and *Joseph W. Eunsielcer*with them, for appellants.

*331
      *R. R.*Larzelere, *J. Morris Yeakle*with him, for appellees.

October 7, 1895:

Opinion by

Mr. Justice Dean,

This case, on the trial, really turned on the question, whether the testatrix, Harriet Y. Shepard, had executed her will in conformity with the statute. Although dated about six months before her death, it was not executed until the first part of December, the month in which she died; she was well advanced in years, and at the time feeble physically.

We think no fair mind, on examination of the testimony, can fail to come to the conclusion that the testator intended the writing in dispute for her last will, and attempted to formally execute it. Whether she succeeded, in conformity to the statute, may be a matter of doubt. But we are not called to pass upon that doubt. We have decided in the appeal of Mary M. Shepard and others from the decree of the orphans’ court awarding this issue, that the creditors, these appellants, have no standing in court as appellants from the decree of the register admitting the will to probate. As the judgment here appealed from sustains the will, we have concluded that the record will be better made up by simply affirming the judgment than by sending it back for further proceedings in the court below. Therefore the judgment is affirmed.
<PAGE>
 
 
                                                                   EXHIBIT 23.2
 
                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
 
  As independent public accountants, we hereby consent to the incorporation of
our report on the combined financial statements of Reunion Energy Company and
Reunion Operating Company (the company) dated March 27, 1996 included in this
Form 10-K, into Reunion Industries, Inc.'s previously filed Registration
Statements on Form S-3 (No. 33-77566) and Form S-8 (No. 33-77232). It should
be noted that we have not audited any financial statements of the company
subsequent to December 31, 1995 or performed any audit procedures subsequent
to the date of our report.
 
                                          ARTHUR ANDERSEN LLP
 
Houston, Texas
March 24, 1998
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 National Science Foundation
 In accordance with the Federal Advisory Committee Act (Pub. L. 92-463, as amended), the National Science Foundation (NSF) announces the following meeting: NAME AND COMMITTEE CODE: MRSEC—Brandeis 2nd Year Virtual Site Visit (1203).
 DATE AND TIME: April 26, 2022; 9:30 a.m.-4:00 p.m.
 PLACE: NSF, 2415 Eisenhower Avenue, Alexandria, VA 22314 | Virtual.
 TYPE OF MEETING: Part-Open.
 CONTACT PERSON: Dr. Miriam Deutsch, Program Director, Division of Materials Research, National Science Foundation, 2415 Eisenhower Avenue, Room W 9216, Alexandria, VA 22314; Telephone: (703) 292-5360.
 PURPOSE OF MEETING: Virtual site visit to provide an evaluation of the progress of the projects at the host site for the Division of Materials Research at the National Science Foundation.
 AGENDA:
 April 26, 2022
9:30 a.m.-10:00 a.m
Brief Charge to Panel
CLOSED.10:00 a.m.-10:10 a.m
Introduction
OPEN.10:10 a.m.-10:55 a.m
Director's Overview
OPEN.10:55 a.m.-11:10 a.m
Discussion/Questions
OPEN.11:10 a.m.-11:30 a.m
IRG-1 Presentation
OPEN.11:30 a.m.-11:35 a.m
Discussion/Questions
OPEN.11:35 a.m.-11:45 a.m
Break
OPEN.11:45 a.m.-12:05 p.m
IRG-2 Presentation
OPEN.12:05 p.m.-12:10 p.m
Discussion/Questions
OPEN.12:10 p.m.-12:35 p.m
Education and Outreach, Diversity Plan
OPEN.12:35 p.m.-12:45 p.m
Discussion/Questions
OPEN.12:45 p.m.-01:30 p.m
Working Lunch
CLOSED.01:30 p.m.-02:30 p.m
Poster Session
OPEN.02:30 p.m.-02:45 p.m
Site Visit Discussion
OPEN.02:45 p.m.-03:30 p.m
Executive Session
CLOSED.03:30 p.m.-04:00 p.m
Debriefing
OPEN.04:00 p.m
Adjourn
 REASON FOR CLOSING: The work being reviewed during closed portions of the virtual site visit include information of a proprietary or confidential nature, including technical information; financial data, such as salaries and personal information concerning individuals associated with the project. These matters are exempt under 5 U.S.C. 552b(c), (4) and (6) of the Government in the Sunshine Act.
 Dated: January 14, 2022. Crystal Robinson, Committee Management Officer.


[FR Doc. 2022-01092 Filed 1-20-22; 8:45 am] BILLING CODE 7555-01-P
[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Page 3565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01241]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NINDS BRAIN Review (U01 and R01) 
Meeting.
    Date: February 17-18, 2022.
    Time: 9:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Mir Ahamed Hossain, Ph.D., Scientific Review 
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience 
Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 
20892-9529, 301-496-9223, <a href="/cdn-cgi/l/email-protection#2c41455e4d444d4149480244435f5f4d45426c424544024b435a"><span class="__cf_email__" data-cfemail="99f4f0ebf8f1f8f4fcfdb7f1f6eaeaf8f0f7d9f7f0f1b7fef6ef">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: January 18, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01241 Filed 1-21-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>